BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37531660)

  • 41. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma.
    Jackow CM; McHam JB; Friss A; Alvear J; Reveille JR; Duvic M
    J Invest Dermatol; 1996 Sep; 107(3):373-6. PubMed ID: 8751973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome.
    Lewis NE; Gao Q; Petrova-Drus K; Pulitzer M; Sigler A; Baik J; Moskowitz AJ; Horwitz SM; Dogan A; Roshal M
    Cytometry B Clin Cytom; 2022 May; 102(3):189-198. PubMed ID: 35451196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
    Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
    Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the novel Sezary lymphoma cell line BKP1.
    Boudjarane J; Essaydi A; Farnault L; Popovici C; Lafage-Pochitaloff M; Beaufils N; Berda-Haddad Y; Lacroix R; Nicolino-Brunet C; Le Treut T; Zattara H; Gabert J; Kahn-Perlès B; Costello R
    Exp Dermatol; 2015 Jan; 24(1):60-2. PubMed ID: 25314094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma.
    Wood GS
    Arch Dermatol; 1998 Feb; 134(2):221-3. PubMed ID: 9487215
    [No Abstract]   [Full Text] [Related]  

  • 50. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetics of Cutaneous T-Cell Lymphomas.
    Hara N; Sawada Y
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.
    Jones CL; Ferreira S; McKenzie RC; Tosi I; Caesar JA; Bagot M; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2012 Aug; 132(8):2042-9. PubMed ID: 22495182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
    Wong HK; Mishra A; Hake T; Porcu P
    Br J Haematol; 2011 Oct; 155(2):150-66. PubMed ID: 21883142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
    Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome.
    Thangavelu M; Finn WG; Yelavarthi KK; Roenigk HH; Samuelson E; Peterson L; Kuzel TM; Rosen ST
    Blood; 1997 May; 89(9):3371-7. PubMed ID: 9129044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.
    Kamstrup MR; Gjerdrum LM; Biskup E; Lauenborg BT; Ralfkiaer E; Woetmann A; Ødum N; Gniadecki R
    Blood; 2010 Oct; 116(14):2504-12. PubMed ID: 20538790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL).
    Bunn PA; Foss FM
    J Cell Biochem Suppl; 1996; 24():12-23. PubMed ID: 8806090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular pathogenesis of cutaneous lymphomas.
    Stadler R; Stranzenbach R
    Exp Dermatol; 2018 Oct; 27(10):1078-1083. PubMed ID: 29862563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.